Evaluation of stability of two types of dental implants placed for the management of edentulous space in healthy and diabetic individuals
- Conditions
- Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
- Registration Number
- CTRI/2023/07/055458
- Lead Sponsor
- Geetha Arul Mohan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion criteria for diabetic individuals:
1.diabetic patients with HbA1C: 6.1-8 [Group III and group IV]
2.Patients who are between 18-60 years of age
3.All sites had to be healed sites, that is at least 6 months of post extraction healing was required
4.Mandibular edentulous sites
Inclusion criteria for healthy individuals:
1.Non diabetic patients with HbA1C- less than 6.1 [Group I and group II]
2.Patients who are between 18-60 years of age
3.All sites had to be healed sites, that is at least 6 months of post extraction healing was required
4.Mandibular edentulous sites
Exclusion criteria for diabetic individuals:
1.HbA1C levels exceeding 8 are excluded
2.History of oral /intravenous bisphosphonate use for >3 years
3.Smokers
4.Pregnancy or lactation
5.Known allergy to any material or medication used in the study
6.Any Previous History of head and neck radiation therapy
7.Chemotherapy in the last 12 months
8.Severe psychologic problems
9.Patient not willing to sign the consent approved by the Human Studies Committee
10.Debilitating systemic diseases or conditions that have a clinically significant effect on wound healing
Exclusion criteria for healthy individuals:
1.HbA1C levels exceeding 6.1 are excluded[Group I and group II]
2.History of oral /intravenous bisphosphonate use for >3 years
3.Smokers
4.Pregnancy or lactation
5.Known allergy to any material or medication used in the study
6.Any Previous History of head and neck radiation therapy
7.Chemotherapy in the last 12 months
8.Severe psychologic problems
9.Patient not willing to sign the consent approved by the Human Studies Committee
10.Debilitating systemic diseases or conditions that have a clinically significant effect on wound
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of secondary stability using Resonance frequency analyser in healthy and diabetic individualsTimepoint: subjects will be followed at baseline, 2 and 4 months
- Secondary Outcome Measures
Name Time Method Evaluation of Primary stability and Crestal bone levels in healthy and diabetic individualsTimepoint: subjects will be followed at baseline, 2 and 4 months